HHMI
BATRK icon

Howard Hughes Medical Institute’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Howard Hughes Medical Institute’s Portfolio BATRK Stock Details BATRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,765
Closed -$31K – 150
2016
Q3 		$31K Sell
1,765
-8,107
-82% -$132K 0.01% 148
2016
Q2 		$145K Buy
+9,872
New +$147K 0.05% 125

Other funds holding BATRK

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
EastBay Asset Management New York $27.9M AUM 37.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Howard Hughes Medical Institute's BATRK Position: Q4 2016 in Review

Howard Hughes Medical Institute sold out of Atlanta Braves Holdings Series B (BATRK) in Q4 2016, closing a stake of 1,765 shares — an estimated $31K sold.

Howard Hughes Medical Institute first reported a position in BATRK in Q2 2016 and held it in 2 quarters. The position peaked at $145K in Q2 2016. 177 funds tracked by Wall St. Rank hold BATRK as of Q4 2016.

  • Howard Hughes Medical Institute reported no remaining Atlanta Braves Holdings Series B position as of Q4 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 1,765 Atlanta Braves Holdings Series B shares in Q4 2016, an estimated $31K.
  • Howard Hughes Medical Institute first reported a position in Atlanta Braves Holdings Series B in Q2 2016 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Atlanta Braves Holdings Series B position peaked at $145K in Q2 2016.
  • 177 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q4 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2016, filed 1 Feb 2017.